Immunovant Inc (IMVT)

Schlusskurs vom Vortag:

$27.49

Offen:

$27.17

24-Stunden-Volumen:

1.17M

Marktkapitalisierung:

$3.99B

Einnahmen:

-

Nettoeinkommen (Verlust:

$-243.45M

KGV:

-14.22

EPS:

-1.93

Netto-Cashflow:

$-210.56M

1W Leistung:

-4.09%

1M Leistung:

-15.07%

6M Leistung:

-16.97%

1J Leistung:

+70.01%

1-Tages-Spanne:

$26.83

$28.57

52-Wochen-Spanne:

$16.58

$45.58

Immunovant Inc Stock (IMVT) Company Profile

Firmenname

Immunovant Inc

Sektor

Healthcare (1191)

Branche

Biotechnology (682)

Telefon

917 580 3099

Adresse

320 West 37th Street, New York, NY

Mitarbeiter

0

Twitter

Nächster Verdiensttermin

2024-05-13

Neueste SEC-Einreichungen

IMVT's Discussions on Twitter

Immunovant Inc Stock (IMVT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-02-15	Eingeleitet	Wolfe Research	Outperform
2023-12-12	Eingeleitet	Deutsche Bank	Buy
2023-10-13	Hochstufung	UBS	Neutral → Buy
2023-09-26	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-05-01	Eingeleitet	BofA Securities	Buy
2023-04-25	Eingeleitet	Citigroup	Buy
2023-03-31	Eingeleitet	Piper Sandler	Overweight
2023-03-30	Eingeleitet	Stifel	Buy
2023-02-15	Eingeleitet	Cantor Fitzgerald	Overweight
2023-02-13	Hochstufung	Guggenheim	Neutral → Buy
2023-01-03	Hochstufung	Wells Fargo	Equal Weight → Overweight
2022-09-26	Herabstufung	UBS	Buy → Neutral
2021-12-08	Eingeleitet	Wells Fargo	Equal Weight
2021-08-03	Herabstufung	Robert W. Baird	Outperform → Neutral
2021-08-02	Herabstufung	Credit Suisse	Neutral → Underperform
2021-06-01	Herabstufung	Guggenheim	Buy → Neutral
2021-06-01	Herabstufung	Stifel	Buy → Hold
2020-10-28	Eingeleitet	UBS	Buy
2020-10-12	Eingeleitet	Guggenheim	Buy
2020-10-08	Eingeleitet	Stifel	Buy
2020-10-02	Eingeleitet	Credit Suisse	Outperform
2020-08-26	Bestätigt	H.C. Wainwright	Buy
2020-08-25	Eingeleitet	Raymond James	Outperform
2020-07-29	Eingeleitet	H.C. Wainwright	Buy
2020-02-24	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Immunovant Inc Aktie (IMVT) Neueste Nachrichten

Here's Why You Should Add Immunovant (IMVT) to Your Portfolio

Zacks Investment Research

What Makes Immunovant (IMVT) a New Buy Stock

Zacks Investment Research

Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday

Zacks Investment Research

Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report?

Zacks Investment Research

Immunovant Awarded U.S. Patent for IMVT-1402

GlobeNewswire Inc.

Here's Why Immunovant, Inc. (IMVT) is Poised for a Turnaround After Losing -8.02% in 4 Weeks

Zacks Investment Research

Finanzdaten der Immunovant Inc-Aktie (IMVT)

Immunovant Inc (IMVT) Nettogewinn 2024

Immunovant Inc (IMVT) Free Cashflow 2024

Immunovant Inc (IMVT) Gewinn je Aktie 2024